Literature DB >> 24125891

Modulation of haloperidol-induced catalepsy in rats by GABAergic neural substrate in the inferior colliculus.

J G Tostes1, P Medeiros, L Melo-Thomas.   

Abstract

Not only is the inferior colliculus (IC) a highly important center of integration within the central auditory pathway, but it may also play a modulatory role in sensory-motor circuitry. Previous evidence from our laboratory relating the IC to motor behavior shows that glutamate-mediated mechanisms within the IC modulate haloperidol-induced catalepsy. The high density of GABAergic receptors in the IC led to this study of a possible link between these receptors, haloperidol-induced catalepsy, and a possible involvement of the blockade of dopaminergic receptors. Catalepsy was evaluated by positioning both forepaws of rats on an elevated horizontal wooden bar and recording the time that the animal maintained this position. The present study shows that haloperidol-induced catalepsy was enhanced by local microinjection into the IC of midazolam (20nmol/0.5μl), a benzodiazepine receptor agonist, whereas animals receiving a microinjection of bicuculline (40 or 80ng/0.5μl), a GABAergic antagonist, showed a reduction in the time of catalepsy. However, the microinjection of haloperidol (2.5 or 5.0μg/0.5μl) bilaterally into the IC did not induce catalepsy. Therefore, our results suggest the involvement of the IC in the modulation of catalepsy induced by haloperidol, even though the dopaminergic mechanisms of the IC are unable to induce catalepsy when blocked by the direct microinjection of haloperidol. It is thus possible that the IC plays a role in sensorimotor gating and that GABA-mediated mechanisms are involved.
Copyright © 2013 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5,10-imine maleate; GABA; IC; MDZ; MK-801; N-methyl-d-aspartate; NMDA; PD; Parkinson’s disease; SNpr; bicuculline; catalepsy; haloperidol; inferior colliculus; midazolam; substantia nigra pars reticulata

Mesh:

Substances:

Year:  2013        PMID: 24125891     DOI: 10.1016/j.neuroscience.2013.09.064

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  The Arousal-motor Hypothesis of Dopamine Function: Evidence that Dopamine Facilitates Reward Seeking in Part by Maintaining Arousal.

Authors:  Marcin Kaźmierczak; Saleem M Nicola
Journal:  Neuroscience       Date:  2022-07-16       Impact factor: 3.708

2.  Effects of GABAa receptor antagonists on motor behavior in pharmacological Parkinson's disease model in mice.

Authors:  Karla De Michelis Mograbi; Ana Carolini Ferreira de Castro; Jainny Aniely Rocha de Oliveira; Patrick Jean Barbosa Sales; Luciene Covolan; Eliane Aparecida Del Bel; Albert Schiaveto de Souza
Journal:  Physiol Rep       Date:  2017-03

3.  Low frequency deep brain stimulation in the inferior colliculus ameliorates haloperidol-induced catalepsy and reduces anxiety in rats.

Authors:  Hannah Ihme; Rainer K W Schwarting; Liana Melo-Thomas
Journal:  PLoS One       Date:  2020-12-04       Impact factor: 3.240

4.  Exploring the Therapeutic Potentials of Highly Selective Oxygenated Chalcone Based MAO-B Inhibitors in a Haloperidol-Induced Murine Model of Parkinson's Disease.

Authors:  Della Grace Thomas Parambi; Uzma Saleem; Muhammad Ajmal Shah; Fareeha Anwar; Bashir Ahmad; Amna Manzar; Aqsa Itzaz; Seetha Harilal; Md Sahab Uddin; Hoon Kim; Bijo Mathew
Journal:  Neurochem Res       Date:  2020-09-16       Impact factor: 3.996

5.  Suppression of motor cortical excitability in anesthetized rats by low frequency repetitive transcranial magnetic stimulation.

Authors:  Paul A Muller; Sameer C Dhamne; Andrew M Vahabzadeh-Hagh; Alvaro Pascual-Leone; Frances E Jensen; Alexander Rotenberg
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

6.  Modafinil Improves Catalepsy in a Rat 6-Hydroxydopamine Model of Parkinson's Disease; Possible Involvement of Dopaminergic Neurotransmission.

Authors:  Reza Vajdi-Hokmabad; Mojtaba Ziaee; Saeed Sadigh-Eteghad; Siamak Sandoghchian Shotorbani; Javad Mahmoudi
Journal:  Adv Pharm Bull       Date:  2017-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.